# Ann S. LaCasce

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ann-s-lacasce/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,269 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 68 |
| i10-index | 175 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5085801543 |
| ORCID iD | https://orcid.org/0000-0001-7349-0176 |
| Works | 394 |

## Researcher papers

- [An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era](https://scholariq.org/papers/an-enhanced-international-prognostic-index-nccn-ipi-for-patients-with-diffuse/)
- [The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice](https://scholariq.org/papers/the-public-repository-of-xenografts-enables-discovery-and-randomized-phase-ii/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.